Tscan Therapeutics
The biggest 3000 companies in the U.S. in the year of 2025.
Rating Overview
Rating Criteria
Rating Criteria Detail
Corporate Weaponization
Criteria:
Has canceled customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.
Risk Level:
LowerRationale:
Tscan has not publicly canceled customers, suppliers, or vendors based on political views or religious beliefs (1).
Criteria:
Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.
Risk Level:
LowerRationale:
Tscan does not appear to discriminate against charitable organizations based on views or beliefs (1).
Criteria:
Employment policies fail to protect against viewpoint or other discrimination and/or are ideological in nature.
Risk Level:
HighRationale:
Tscan appears to prioritize diversity over merit in its leadership composition. From its 2025 Annual Report: “the nominating and corporate governance committee and the full board of directors are committed to creating a board of directors with diversity, including diversity of expertise, experience, background, race and gender, and are committed to identifying, recruiting and advancing candidates offering such diversity in future searches” (1). The company does not provide viewpoint protections for its employees (2)(3).
Corporate Governance and Public Policy
Criteria:
Uses corporate reputation to support causes, organizations, or policies hostile to freedom of expression.
Risk Level:
LowerRationale:
Tscan has not supported ideological causes or policies (1).
Criteria:
Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.
Risk Level:
LowerRationale:
Tscan has not used corporate funds to advance ideological causes, organizations, or policies (1).